[go: up one dir, main page]

PL3853218T3 - Modulatory somatostatyny i ich zastosowania - Google Patents

Modulatory somatostatyny i ich zastosowania

Info

Publication number
PL3853218T3
PL3853218T3 PL19863395.0T PL19863395T PL3853218T3 PL 3853218 T3 PL3853218 T3 PL 3853218T3 PL 19863395 T PL19863395 T PL 19863395T PL 3853218 T3 PL3853218 T3 PL 3853218T3
Authority
PL
Poland
Prior art keywords
somatostatin modulators
somatostatin
modulators
Prior art date
Application number
PL19863395.0T
Other languages
English (en)
Inventor
Sangdon Han
Sun Hee Kim
Yunfei Zhu
Original Assignee
Crinetics Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinetics Pharmaceuticals, Inc. filed Critical Crinetics Pharmaceuticals, Inc.
Publication of PL3853218T3 publication Critical patent/PL3853218T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL19863395.0T 2018-09-18 2019-09-17 Modulatory somatostatyny i ich zastosowania PL3853218T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862732735P 2018-09-18 2018-09-18
PCT/US2019/051514 WO2020061046A1 (en) 2018-09-18 2019-09-17 Somatostatin modulators and uses thereof

Publications (1)

Publication Number Publication Date
PL3853218T3 true PL3853218T3 (pl) 2025-06-02

Family

ID=69772634

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19863395.0T PL3853218T3 (pl) 2018-09-18 2019-09-17 Modulatory somatostatyny i ich zastosowania

Country Status (17)

Country Link
US (4) US10696689B2 (pl)
EP (2) EP3853218B1 (pl)
JP (1) JP7431813B2 (pl)
AR (1) AR116424A1 (pl)
DK (1) DK3853218T3 (pl)
ES (1) ES3022912T3 (pl)
FI (1) FI3853218T3 (pl)
HR (1) HRP20250425T1 (pl)
HU (1) HUE071203T2 (pl)
LT (1) LT3853218T (pl)
PL (1) PL3853218T3 (pl)
PT (1) PT3853218T (pl)
RS (1) RS66720B1 (pl)
SI (1) SI3853218T1 (pl)
SM (1) SMT202500155T1 (pl)
TW (1) TWI852944B (pl)
WO (1) WO2020061046A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3484865T3 (pl) 2016-07-14 2023-01-09 Crinetics Pharmaceuticals, Inc. Modulatory somatostatyny i ich zastosowania
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
WO2019157458A1 (en) 2018-02-12 2019-08-15 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
JP7431813B2 (ja) 2018-09-18 2024-02-15 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターとその使用
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
SMT202500315T1 (it) 2020-09-09 2025-11-10 Crinetics Pharmaceuticals Inc Formulazioni di un modulatore della somatostatina
CN117043149A (zh) * 2021-02-17 2023-11-10 克林提克斯医药股份有限公司 促生长素抑制素调节剂的结晶形式
US20240254106A1 (en) * 2022-12-13 2024-08-01 Crinetics Pharmaceuticals, Inc. Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127343A (en) * 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
US20060281764A1 (en) 2005-06-10 2006-12-14 Gaul Michael D Aminopyrimidines as kinase modulators
AU2007309708A1 (en) 2006-03-13 2008-05-02 Merck Sharp & Dohme Corp. Somatostatin agonists
BRPI0715967A2 (pt) 2006-08-15 2013-08-06 Hoffmann La Roche compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodos para o tratamento e/ou prevenÇço de enfermidades que estço associadas com a modulaÇço de receptores de sst do subtipo 5, e uso destes compostos
WO2009051705A1 (en) 2007-10-18 2009-04-23 Merck & Co., Inc. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
AU2009262150A1 (en) 2008-06-25 2009-12-30 Envivo Pharmaceuticals, Inc. Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
EP2473500A2 (en) 2009-09-01 2012-07-11 Pfizer Inc. Benzimidazole derivatives
GB201008290D0 (en) 2010-05-18 2010-06-30 Syngenta Ltd Chemical compounds
EP2571356A4 (en) 2010-05-18 2013-11-20 Merck Sharp & Dohme SPIROISOXAZOLIN COMPOUNDS AS SSTR5 ANTAGONISTS
EP2871179A4 (en) 2012-07-03 2016-03-16 Ono Pharmaceutical Co CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
TWI628175B (zh) 2013-09-30 2018-07-01 日商小野藥品工業股份有限公司 具有體抑素受體致效活性的化合物及其醫藥用途
US10093795B2 (en) 2013-10-02 2018-10-09 Kuraray Co., Ltd. Resin composition, multilayer sheet, packaging material and container
PL3484865T3 (pl) 2016-07-14 2023-01-09 Crinetics Pharmaceuticals, Inc. Modulatory somatostatyny i ich zastosowania
JP6838387B2 (ja) * 2016-12-21 2021-03-03 トヨタ紡織株式会社 内装部品の取付構造
AU2018219644A1 (en) 2017-02-08 2019-08-29 Ono Pharmaceutical Co., Ltd. Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
WO2019023278A1 (en) 2017-07-25 2019-01-31 Crinetics Pharmaceuticals, Inc. MODULATORS OF SOMATOSTATIN AND USES THEREOF
WO2019157458A1 (en) 2018-02-12 2019-08-15 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
JP7431813B2 (ja) * 2018-09-18 2024-02-15 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターとその使用
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途

Also Published As

Publication number Publication date
HUE071203T2 (hu) 2025-08-28
HRP20250425T1 (hr) 2025-06-20
US20220048924A1 (en) 2022-02-17
US11186590B2 (en) 2021-11-30
TW202024095A (zh) 2020-07-01
US20230022513A1 (en) 2023-01-26
JP7431813B2 (ja) 2024-02-15
TWI852944B (zh) 2024-08-21
AR116424A1 (es) 2021-05-05
US11834462B2 (en) 2023-12-05
PT3853218T (pt) 2025-04-02
EP3853218A4 (en) 2022-02-16
EP3853218A1 (en) 2021-07-28
ES3022912T3 (en) 2025-05-29
US10696689B2 (en) 2020-06-30
US20200283453A1 (en) 2020-09-10
LT3853218T (lt) 2025-05-12
SI3853218T1 (sl) 2025-06-30
DK3853218T3 (da) 2025-04-22
EP4548974A3 (en) 2025-08-13
WO2020061046A1 (en) 2020-03-26
EP4548974A2 (en) 2025-05-07
US20200087318A1 (en) 2020-03-19
JP2022501342A (ja) 2022-01-06
FI3853218T3 (fi) 2025-04-15
SMT202500155T1 (it) 2025-05-12
EP3853218B1 (en) 2025-02-19
RS66720B1 (sr) 2025-05-30

Similar Documents

Publication Publication Date Title
IL269241A (en) Somatostatin modulators and their uses
ZA201900317B (en) Somatostatin modulators and uses thereof
ZA202002184B (en) Adenovirus and uses thereof
IL274219A (en) Adenovirus and its uses
IL294052B1 (en) Fluoroalkyl oxadiazoles and their uses
PL3853218T3 (pl) Modulatory somatostatyny i ich zastosowania
EP3317277A4 (en) Somatostatin modulators and uses thereof
IL277502A (en) Compounds and uses for them
ZA202105847B (en) Mtroc modulators and uses thereof
IL280808A (en) OX40-binding polypeptides and their uses
EP3317278A4 (en) Somatostatin modulators and uses thereof
IL277548A (en) Modulators of caplain and their medicinal uses
IL274220A (en) Adenovirus and its uses
SG11202006669RA (en) Peptides and uses thereof
IL287503A (en) Thio-semicarbazide compounds and their use
IL279483A (en) Cyanotriazole compounds and their uses
ZA201905513B (en) Rorgamma modulators and uses thereof
ZA201905511B (en) Rorgamma modulators and uses thereof
IL273671A (en) Cornoline variants and their use
IL280369A (en) Myokines and their uses
HUE068738T2 (hu) Új szelektív ACKR3-modulátorok és alkalmazásaik
HK40016459A (en) Rorgamma modulators and uses thereof
HK40016461A (en) Rorgamma modulators and uses thereof
HK40016442A (en) Rorgamma modulators and uses thereof
GB201812328D0 (en) Polypeptides and uses thereof